Kalbe Farma Tbk PT
OTC:PTKFF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kalbe Farma Tbk PT
OTC:PTKFF
|
ID |
|
G
|
GMK Noril'skiy Nikel' PAO
VSE:MNOD
|
RU |
|
C
|
Carter's Inc
XMUN:HCH
|
US |
|
Shin-Etsu Chemical Co Ltd
F:SEH0
|
JP |
|
UniCredit SpA
F:CRIN
|
IT |
|
G
|
G8 Education Ltd
F:3EAG
|
AU |
|
U
|
United Utilities Group PLC
F:UUEC
|
UK |
Wall St Price Targets
PTKFF Price Targets Summary
Kalbe Farma Tbk PT
According to Wall Street analysts, the average 1-year price target for
PTKFF is 0.0677 USD with a low forecast of 0.0425 USD and a high forecast of 0.0922 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PTKFF's stock price target?
Price Target
0.0677
USD
According to Wall Street analysts, the average 1-year price target for
PTKFF is 0.0677 USD with a low forecast of 0.0425 USD and a high forecast of 0.0922 USD.
What is the Revenue forecast for Kalbe Farma Tbk PT?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 9%.
What is the Gross Profit forecast for Kalbe Farma Tbk PT?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Kalbe Farma Tbk PT?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is 6%.
What is the Pre-Tax Income forecast for Kalbe Farma Tbk PT?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 6%. The projected CAGR for the next 3 years is 3%.
What is the Net Income forecast for Kalbe Farma Tbk PT?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is 8%.